A Dose-Response Relationship Study of Prophylactic Nalbuphine to Reduce Pain During the Awakening Period in Patients Undergoing Laparoscopic Total Hysterectomy: A Randomized, Controlled, Double-Blind Clinical Study

PURPOSE: Prophylactic intravenous nalbuphine was administered to observe its median effective dose (ED(50)) in reducing pain after undergoing laparoscopic total hysterectomy. To investigate the effect of different doses of nalbuphine on postoperative analgesia and adverse reactions in patients. PATI...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Min, Wang, Dongyue, Zuo, Jingzhi, Liu, Tianyu, Niu, Zheng, Xie, Juan, Qi, Dunyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979566/
https://www.ncbi.nlm.nih.gov/pubmed/35386854
http://dx.doi.org/10.2147/DDDT.S356582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979566/
https://www.ncbi.nlm.nih.gov/pubmed/35386854
http://dx.doi.org/10.2147/DDDT.S356582

Ejemplares similares